Please provide your email address to receive an email when new articles are posted on . In patients who underwent surgical bioprosthetic valve implantation or repair, early postoperative ...

Very elderly people with nonvalvular atrial fibrillation (Afib) got the same stroke prevention benefits from edoxaban (Savaysa) and apixaban (Eliquis), though one drug was associated with more major ...

LISBON, Portugal—Use of uninterrupted edoxaban (Savaysa; Daiichi Sankyo) during catheter ablation for A-fib is associated with rates of thromboembolic and bleeding events that are low and comparable ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — For children with rare heart conditions that increase risk for thromboembolism, daily edoxaban may be ...

WASHINGTON, DC—In another negative result for a direct oral anticoagulant in the post-TAVI setting, edoxaban (Savaysa; Daiichi Sankyo) did not have an advantage over dual antiplatelet therapy (DAPT) ...

Treatment with the direct factor Xa inhibitor edoxaban (Lixiana) resulted in low rates of clinically relevant bleeding and thromboembolism (TE) compared with standard-of-care (SOC) anticoagulants in ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Elderly patients with atrial fibrillation (AF) who are at high risk of bleeding may benefit from a low 15-mg dose of edoxaban, regardless of their frailty status, a subanalysis of the ELDERCARE-AF ...

Boston, MA – According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Stroke is the leading cause of serious ...

A new study compares edoxaban anticoagulant with the standard of care in large randomized clinical trial. The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or ...

Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: final matrix Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - ...

Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: final matrix Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - ...